Two years into the Vax2Muc project, results are starting to emerge, and the researchers are busy presenting their findings at scientific conferences. This year, three posters have been presented so far, each of them bringing more insight towards the overall goal of new vaccine development.

Last year, the National Cancer Institute convened a forum of international gastric cancer experts, including Vax2Muc’s coordinator, Markus Gerhard. Key insights from the forum have now been published in a summary report.

On the occasion of World Immunisation Week 2025, we spoke with Martina Bardino Mørch, a PhD student at the Statens Serum Institut in Denmark. We asked her about her work, Vax2Muc research collaboration, and the project's contribution to innovative vaccine research.

18 months into the project and as part of the project implementation cycle, the European Commission represented by the Health and Digital Executive Agency invited the Vax2Muc consortium for a first review meeting to evaluate the progress achieved.

On 5 and 6 March, Vax2Muc held its regular virtual project progress meeting, bringing together experts from all over Europe to discuss the current status and coordinate future steps.

On the occasion of the International Day of Women and Girls in Science, we spoke with Nicole O’Sullivan, a PhD student at Trinity College Dublin (TCD). We asked her about her current work on the Vax2Muc project and experiences as a young woman active in this field of research.

To advance cancer vaccine science, collaboration is essential. TRANSVAC was a collaborative network designed to provide comprehensive support to vaccine developers and offer access to crucial vaccine development infrastructure to research projects, including Vax2Muc.

This year’s World Antimicrobial Resistance Awareness Week is around the corner, and its mission – educating about the ongoing antimicrobial resistance crisis – is as important as ever. Here’s how Vax2Muc contributes to the fight against antibiotic resistance.

Vax2Muc partners met in Lisbon from 16 to 17 September to discuss project progress, brainstorm, and plan future activities.

Meet Vax2Muc scientist Cora Mibus from the Technical University of Munich. She is a doctoral student at TUM’s Institute of Medical Microbiology, Immunology and Hygiene and contributes to the Vax2Muc research as part of the network of international experts.

European Commission’s recent proposal on vaccine-preventable cancers included the EU-funded Vax2Muc project as an example of ongoing vaccine development to prevent gastric cancer.

Vax2Muc partners met in Copenhagen from March 13 to 14 to discuss vaccine research progress. With the vaccine design ending, the project's next stage will focus on trial vaccine production.

Eight months into the project, a group of Vax2Muc researchers from Helmholtz Centre for Infection Research (HZI), Statens Serum Institut (SSI), Technical University of Munich (TUM), and Trinity College Dublin (TCD) met in Munich to jointly explore technics and protocols for their future collaboration.

29 November 2023 - We are thrilled to announce the official launch of the Vax2Muc project website! 🚀